Cargando…
Clinical Application of Pharmacogenetics: Where are We Now?
Pharmacogenetic (PGx) testing has the potential to improve drug therapy in an individual by informing appropriate drug dosing or drug selection in order to maximize efficacy and safety. Although multiple studies have illustrated the potential benefits of such testing when applied to specific drugs a...
Autor principal: | van Schaik, Ron HN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975184/ https://www.ncbi.nlm.nih.gov/pubmed/27683445 |
Ejemplares similares
-
6. Dose Adjustments Based on Pharmacogenetics of CYP450 Enzymes
por: van Schaik, Ron H.N.
Publicado: (2008) -
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023) -
Where are we now?
Publicado: (1977) -
Angiogenesis inhibitors in clinical development; where are we now and where are we going?
por: Eskens, F A L M
Publicado: (2004) -
NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)